136 related articles for article (PubMed ID: 28861044)
1. Diabetic Neuropathy Evaluated by a Novel Device: Sural Nerve Conduction Is Associated with Glycemic Control and Ankle-Brachial Pressure Index in Japanese Patients with Diabetes.
Hamasaki H; Hamasaki Y
Front Endocrinol (Lausanne); 2017; 8():203. PubMed ID: 28861044
[TBL] [Abstract][Full Text] [Related]
2. A Comparison of Screening Tools for the Early Detection of Peripheral Neuropathy in Adults with and without Type 2 Diabetes.
Brown JJ; Pribesh SL; Baskette KG; Vinik AI; Colberg SR
J Diabetes Res; 2017; 2017():1467213. PubMed ID: 29250555
[TBL] [Abstract][Full Text] [Related]
3. A 10-yr follow-up study for the detection of peripheral neuropathy in young patients with type 1 diabetes.
Hajas G; Kissova V; Tirpakova A
Pediatr Diabetes; 2016 Dec; 17(8):632-641. PubMed ID: 27028140
[TBL] [Abstract][Full Text] [Related]
4. Vascular factors and neuropathy in lower limb of diabetic patients.
Kim SE; Park KM; Park J; Ha SY; Kim SE; Lee BI; Shin KJ
J Clin Neurosci; 2019 Jan; 59():130-135. PubMed ID: 30420207
[TBL] [Abstract][Full Text] [Related]
5. Association between Diabetic Peripheral Neuropathy as Measured Using a Point-of-Care Sural Nerve Conduction Device and Urinary Albumin Excretion in Patients with Type 2 Diabetes.
Fukuda T; Fujii A; Akihisa T; Otsubo N; Murakami M; Yamada T; Maki C
J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373782
[TBL] [Abstract][Full Text] [Related]
6. Reliability and validity of a point-of-care sural nerve conduction device for identification of diabetic neuropathy.
Lee JA; Halpern EM; Lovblom LE; Yeung E; Bril V; Perkins BA
PLoS One; 2014; 9(1):e86515. PubMed ID: 24466129
[TBL] [Abstract][Full Text] [Related]
7. Assessment of diabetic neuropathy using a point-of-care nerve conduction device shows significant associations with the LDIFLARE method and clinical neuropathy scoring.
Sharma S; Vas PR; Rayman G
J Diabetes Sci Technol; 2015 Jan; 9(1):123-31. PubMed ID: 25231114
[TBL] [Abstract][Full Text] [Related]
8. Sural sensory action potential identifies diabetic peripheral neuropathy responders to therapy.
Vinik AI; Bril V; Litchy WJ; Price KL; Bastyr EJ;
Muscle Nerve; 2005 Nov; 32(5):619-25. PubMed ID: 16116628
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamin B12, and Carnitine for 12 Months in Patients with Diabetic Neuropathy.
Didangelos T; Karlafti E; Kotzakioulafi E; Kontoninas Z; Margaritidis C; Giannoulaki P; Kantartzis K
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33114210
[TBL] [Abstract][Full Text] [Related]
10. Lower Visceral Fat Area in Patients with Type 2 Diabetic Peripheral Neuropathy.
Wu Y; Wan Q; Xu Y; Li J; Li K; Zhang Z; Tang Q; Miao Y; Yan P
Diabetes Metab Syndr Obes; 2022; 15():3639-3654. PubMed ID: 36439295
[TBL] [Abstract][Full Text] [Related]
11. Glycemic Variability and Diabetic Neuropathy in Young Adults With Type 1 Diabetes.
Christensen MMB; Hommel EE; Jørgensen ME; Fleischer J; Hansen CS
Front Endocrinol (Lausanne); 2020; 11():644. PubMed ID: 33071962
[No Abstract] [Full Text] [Related]
12. Evaluation of sural nerve automated nerve conduction study in the diagnosis of peripheral neuropathy in patients with type 2 diabetes mellitus.
Chatzikosma G; Pafili K; Demetriou M; Vadikolias K; Maltezos E; Papanas N
Arch Med Sci; 2016 Apr; 12(2):390-3. PubMed ID: 27186185
[TBL] [Abstract][Full Text] [Related]
13. Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy.
Perkins BA; Grewal J; Ng E; Ngo M; Bril V
Diabetes Care; 2006 Sep; 29(9):2023-7. PubMed ID: 16936147
[TBL] [Abstract][Full Text] [Related]
14. Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point-of-care device for nerve conduction studies.
Morita M; Sada K; Hidaka S; Ogawa M; Shibata H
J Diabetes Investig; 2024 Apr; ():. PubMed ID: 38685597
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of epalrestat plus α-lipoic acid combination therapy
Zhao M; Chen JY; Chu YD; Zhu YB; Luo L; Bu SZ
Neural Regen Res; 2018 Jun; 13(6):1087-1095. PubMed ID: 29926837
[TBL] [Abstract][Full Text] [Related]
16. Point-of-care nerve conduction device predicts the severity of diabetic polyneuropathy: A quantitative, but easy-to-use, prediction model.
Kamiya H; Shibata Y; Himeno T; Tani H; Nakayama T; Murotani K; Hirai N; Kawai M; Asada-Yamada Y; Asano-Hayami E; Nakai-Shimoda H; Yamada Y; Ishikawa T; Morishita Y; Kondo M; Tsunekawa S; Kato Y; Baba M; Nakamura J
J Diabetes Investig; 2021 Apr; 12(4):583-591. PubMed ID: 32799422
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of dorsal sural nerve conduction studies in healthy and diabetic children.
Turgut N; Karasalihoglu S; Kücükugurluoglu Y; Balci K; Ekuklu G; Tütüncüler F
Clin Neurophysiol; 2004 Jun; 115(6):1452-6. PubMed ID: 15134714
[TBL] [Abstract][Full Text] [Related]
18. Cross-Sectional Study of the Relationship Between Medial Plantar Nerve Conduction Studies and Severity of Diabetic Neuropathy.
Kartheka R; Aghoram R; Faith AJ; Wadwekar V
Ann Indian Acad Neurol; 2024; 27(2):183-187. PubMed ID: 38751930
[TBL] [Abstract][Full Text] [Related]
19. Superficial radial sensory nerve potentials in immune-mediated and diabetic neuropathies.
Tamura N; Kuwabara S; Misawa S; Mori M; Nakata M; Hattori T
Clin Neurophysiol; 2005 Oct; 116(10):2330-3. PubMed ID: 16122982
[TBL] [Abstract][Full Text] [Related]
20. High-resolution ultrasonography of the sural nerve in diabetic peripheral neuropathy.
Singh KP; Gupta K; Kataria N; Arora V; Nagpal N
J Ultrason; 2020; 20(81):e83-e89. PubMed ID: 32609965
[No Abstract] [Full Text] [Related]
[Next] [New Search]
